Deutsch English Français

Contact

EP2917235

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2917235

EP2917235 - ANTIBODY COMPOSITIONS AND IMMUNOASSAY METHODS TO DETECT ISOFORMS OF ANTI-MULLERIAN HORMONE [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 02.10.2020 Database last updated on 29.10.2024
Former	Examination is in progress Status updated on 15.09.2017
Former	Request for examination was made Status updated on 11.04.2017
Most recent event Tooltip	02.10.2020	Application deemed to be withdrawn	published on 04.11.2020 [2020/45]
Applicant(s)	For all designated states Ansh Labs LLC 445 Medical Center Boulevard Webster, TX 77598 / US
	[2015/38]
Inventor(s)	01 / GOPAL, V., Savjani 319 Lakeshore Drive El Lago, TX 77586 / US
	02 / AJAY, Kumar 3714 Arbor Point Lane Friendswood, TX 77546 / US
	[2015/38]
Representative(s)	Høiberg P/S, et al Adelgade 12 1304 Copenhagen K / DK
	[N/P]
Former [2015/38]	Aamand, Jesper L. Jesper Levin A/S Strandvejen 656 2930 Klampenborg / DK
Application number, filing date	13853068.8	08.11.2013
	[2015/38]
	WO2013US69172
Priority number, date	US201261724485P	09.11.2012 Original published format: US 201261724485 P
	US201361835420P	14.06.2013 Original published format: US 201361835420 P
	US201361889868P	11.10.2013 Original published format: US 201361889868 P
	[2015/38]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2014074835
	Date:	15.05.2014
	Language:	EN
	[2014/20]
	Type:	A2 Application without search report
	No.:	EP2917235
	Date:	16.09.2015
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 15.05.2014 takes the place of the publication of the European patent application.
	[2015/38]
Search report(s)	International search report - published on:	US	24.07.2014
	(Supplementary) European search report - dispatched on:	EP	02.08.2016
Classification	IPC:	C07K16/00, G01N33/68, A61K39/395, G01N33/74	[2016/22]
	CPC:	G01N33/74 (EP,US); C07K16/26 (US); G01N33/6863 (EP,US); G01N2333/575 (US)
	Former IPC [2015/38]	C07K16/00, G01N33/00, A61K39/395
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/38]
Title	German:	ANTIKÖRPERZUSAMMENSETZUNGEN UND IMMUNOASSAY-VERFAHREN FÜR DEN NACHWEIS VON ISOFORMEN DES ANTI-MÜLLER-HORMONS	[2015/38]
	English:	ANTIBODY COMPOSITIONS AND IMMUNOASSAY METHODS TO DETECT ISOFORMS OF ANTI-MULLERIAN HORMONE	[2015/38]
	French:	COMPOSITIONS D'ANTICORPS ET PROCÉDÉS D'IMMUNODOSAGE POUR DÉTECTER DES ISOFORMES DE L'HORMONE ANTIMÜLLÉRIENNE	[2015/38]
Entry into regional phase	09.06.2015	National basic fee paid
	09.06.2015	Search fee paid
	09.06.2015	Designation fee(s) paid
	09.06.2015	Examination fee paid
Examination procedure	09.06.2015	Examination requested [2015/38]
	22.06.2017	Amendment by applicant (claims and/or description)
	18.09.2017	Despatch of a communication from the examining division (Time limit: M06)
	28.03.2018	Reply to a communication from the examining division
	09.08.2018	Despatch of a communication from the examining division (Time limit: M06)
	27.05.2019	Reply to a communication from the examining division
	16.12.2019	Despatch of a communication from the examining division (Time limit: M06)
	03.06.2020	Application deemed to be withdrawn, date of legal effect [2020/45]
	29.06.2020	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2020/45]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 18.09.2017
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the examination report
	27.05.2019	Request for further processing filed
	27.05.2019	Full payment received (date of receipt of payment) Request granted
	07.06.2019	Decision despatched
	The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
	22.06.2017	Request for further processing filed
	22.06.2017	Full payment received (date of receipt of payment) Request granted
	17.07.2017	Decision despatched
	The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
	22.06.2017	Request for further processing filed
	22.06.2017	Full payment received (date of receipt of payment) Request granted
	17.07.2017	Decision despatched
Fees paid	Renewal fee
	30.11.2015	Renewal fee patent year 03
	30.11.2016	Renewal fee patent year 04
	30.11.2017	Renewal fee patent year 05
	30.11.2018	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	30.11.2019	07 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]WO03022998 (CURAGEN CORP [US], et al) [A] 1-4,11,14-20 * claim 29; sequence 20 *
		[I] - KUMAR A ET AL, "Development of a second generation anti-Mullerian hormone (AMH) ELISA", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 362, no. 1-2, doi:10.1016/J.JIM.2010.08.011, ISSN 0022-1759, (20101031), pages 51 - 59, (20100827), XP027509590 [I] 1-4,11,14-20 * abstract * * page 52, column l, paragraph 3 * DOI: http://dx.doi.org/10.1016/j.jim.2010.08.011
	International search	[A]US2006275850 (GROOME NIGEL P [GB], et al);
		[A]US2009304675 (MCLENNAN IAN STUART [NZ], et al)
		[A] - "MUELLERIAN-INHIBITING FACTOR PRECURSOR [HOMO SAPIENS]", PROTEIN, (20121204), Database accession no. NP_000470, URL: NCBI, XP055255360
		[A] - DI CLEMENTE ET AL., "Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.", MOL ENDOCRINOL., (2010), vol. 24, no. 11, pages 2193 - 2206, XP055108341 DOI: http://dx.doi.org/10.1210/me.2010-0273
		[A] - AL-QAHTANI ET AL., "Development of a sensitive enzyme immunoassay for Anti-Mullerian Hormone (AMH) and the evaluation of potential clinical applications in males and females.", CLIN. ENDOCRINOL., (2005), vol. 63, no. 3, pages 267 - 273, XP055241300 DOI: http://dx.doi.org/10.1111/j.1365-2265.2005.02336.x

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p